Qiagen NV Bolsters Bundibugyo Ebola Research
Qiagen NV has introduced two custom-designed digital PCR assays to aid research and surveillance of the Bundibugyo ebolavirus outbreak. These assays are specifically designed for research use and are not approved for diagnostic purposes. The company is focused on enhancing infectious disease research through innovative solutions.
Devdiscourse News Desk | May 28 (Reuters) - Qiagen Nv: * Qiagen Nv: Qiagen Supports Infectious Disease Research And
Surveillance Efforts For Bundibugyo Ebolavirus Outbreak* Qiagen: 2 Custom-Designed Research-Use-Only Qiacuity
Digital Pcr Assays Available To Target Bundibugyo Ebola
Sequences Associated With Current Outbreak * Qiagen Nv: Assays Are Intended For Research Use Only And
Are Not Intended For Diagnostic Procedures
Source Text:
Further Company Coverage: | Updated: 29-05-2026 01:38 IST | Created: 29-05-2026 01:38 IST
Qiagen NV has taken significant steps to support the research and monitoring of the Bundibugyo ebolavirus outbreak by unveiling two custom-designed digital PCR assays. These tools are crafted to precisely target Bundibugyo Ebola sequences.
While these assays provide vital support in research, they are strictly intended for research purposes rather than diagnostic procedures. The company's innovation underscores its commitment to bolstering infectious disease research efforts.
The introduction of these assays is a part of Qiagen's broader strategy to enhance capabilities in addressing infectious disease outbreaks worldwide, highlighting the importance of targeted research tools.
(With inputs from agencies.)
Advertisement
Google News